PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsEsomeprazole strontium
Esomeprazole strontium
Nexium Control (esomeprazole strontium) is a small molecule pharmaceutical. Esomeprazole strontium was first approved as Esomeprazole strontium on 2013-08-06. It is used to treat duodenal ulcer, esophagitis, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. It has been approved in Europe to treat gastroesophageal reflux.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
neoplasmsD009369
digestive system diseasesD004066
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
acid reducerANDA2024-02-15
basic care esomeprazole magnesiumANDA2024-07-25
berkley and jensen heartburn treatmentANDA2024-07-31
careone esomeprazole magnesiumANDA2019-12-18
dg health esomeprazole magnesiumANDA2024-08-02
equaline esomeprazole magnesiumANDA2024-08-01
esomeprazoleANDA2023-11-03
esomeprazole drANDA2023-08-23
esomeprazole magnesiumANDA2024-10-23
esomeprazole magnesium delayed-release 20 mg mini esomeprazole magnesium delayed-release capsules, 20 mgANDA2024-03-18
Show 21 more
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A02: Drugs for acid related disorders
A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BC: Proton pump inhibitors for peptic ulcer and gord
A02BC05: Esomeprazole
A02BD: Combinations for eradication of helicobacter pylori
A02BD06: Esomeprazole, amoxicillin and clarithromycin
M: Musculo-skeletal system drugs
M01: Antiinflammatory and antirheumatic products
M01A: Antiinflammatory and antirheumatic products, non-steroids
M01AE: Propionic acid derivatives, antiinflammatory and antirheumatic products
M01AE52: Naproxen and esomeprazole
HCPCS
No data
Clinical
Clinical Trials
528 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gastroesophageal refluxD005764EFO_0003948K21919303624115
InfectionsD007239EFO_00005442596133107
Healthy volunteers/patients56116265
Helicobacter infectionsD016481EFO_1000961259251957
Peptic esophagitisD004942EFO_1001095171481039
UlcerD014456MPATH_579221710637
Communicable diseasesD003141134151334
GastritisD005756EFO_0000217K29.731517632
EsophagitisD004941HP_0100633K2028126431
Peptic ulcerD010437HP_0004398K2731416630
Show 69 more
Indications Phases 2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD010599415
Therapeutic equivalencyD01381044
Pharmacological phenomenaD00006943722
HypertensionD006973EFO_0000537I1011
Pulmonary hypertensionD006976EFO_0001361I27.2011
Pulmonary arterial hypertensionD00008102911
Hepatitis bD00650911
Chronic hepatitis bD019694EFO_0004239B18.111
HyperplasiaD006965EFO_000053611
LymphomaD008223C85.911
Show 12 more
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEsomeprazole strontium
INNesomeprazole
Description
Nexium Control (esomeprazole strontium) is a small molecule pharmaceutical. Esomeprazole strontium was first approved as Esomeprazole strontium on 2013-08-06. It is used to treat duodenal ulcer, esophagitis, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. It has been approved in Europe to treat gastroesophageal reflux.
Classification
Small molecule
Drug classantiulcer agents (benzimidazole derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.O.O.O.O.[Sr+2]
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2146140
ChEBI ID
PubChem CID16048656
DrugBank
UNII IDN3PA6559FT (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,669 documents
View more details
Safety
Black-box Warning
Black-box warning for: Naproxen and esomeprazole magnesium, Vimovo
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
74,401 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use